Skip to main content

Jim Cramer Says Buy a Cyclical Stock Instead of a Vaccine Maker

Publish date:
Video Rating:
Video Duration:

Pfizer  (PFE) - Get Pfizer Inc. Report officially applied for Emergency Use Authorization for its developed coronavirus vaccine from the Food & Drug Administration and said it could be available for high-risk patients as early as December.

Pfizer and BioNTech's  (BNTX) - Get BioNTech SE Report vaccine candidate, BNT162b2, reached a 95% efficacy rate across all age and race demographics and based on a total case-cohort of 170 and reiterated their aim of having 1.3 billion doses available next year and 50 million doses before the end of the year. 

Watch: Everything Jim Cramer Is Watching in Markets Friday

You can follow Jim Cramer and Katherine Ross on Twitter at @JimCramer and @byKatherineRoss. Read more from Katherine Ross here.

Latest Videos From TheStreet and Jim Cramer:

Related Videos